Connecting...

This is a quick preview of the lesson. For full access, please Log In or Sign up.
For more information, please see full course syllabus of Microbiology
For more information, please see full course syllabus of Microbiology
Microbiology Tumor Immunology
Lecture Description
In this lesson, our instructor Catherine Carpenter gives an introduction on tumor immunology. She discusses antibodies surrounding the tumor, Human Papilloma, Hepatitis B, Helicobacter Pylori, and Immunology. She then explains the Immune Surveilance Theory, Malignant Transformation, immune reactivity to tumors, tumor antigens, tumor immunotherapies, inflammation and cancer. Next, she continues with tumor growth over time and carcinogenesis.
Bookmark & Share
Embed
Share this knowledge with your friends!
Copy & Paste this embed code into your website’s HTML
Please ensure that your website editor is in text mode when you paste the code.(In Wordpress, the mode button is on the top right corner.)
×
Since this lesson is not free, only the preview will appear on your website.
- - Allow users to view the embedded video in full-size.
Next Lecture
Previous Lecture
0 answers
Post by Professor Catherine Carpenter Carpenter on May 7, 2019
You need to figure out what you are developing a vaccine for. Remember 'malaria' is a disease that involves a vector mosquito, and a parasite that the mosquito carries. Some brand new research is developing gene therapy for the mosquito, essentially making them sterile. You could potentially make a vaccine for the parasite, but parasitic vaccine development is fairly challenging. Alternatively you could make a vaccine for one of the early larval stages of the parasite. You might have more luck there.
Thank you for question,
Catherine Carpenter, Ph.D.
0 answers
Post by Maryam Fayyazi on May 7, 2019
Thanks for the amazing lecture. If we were to design a vaccine for malaria which unique protein or gene has better chance for successful vaccine?